NZ598121A - Nitroimidazooxazines and their uses in anti-tubercular therapy - Google Patents
Nitroimidazooxazines and their uses in anti-tubercular therapyInfo
- Publication number
- NZ598121A NZ598121A NZ598121A NZ59812110A NZ598121A NZ 598121 A NZ598121 A NZ 598121A NZ 598121 A NZ598121 A NZ 598121A NZ 59812110 A NZ59812110 A NZ 59812110A NZ 598121 A NZ598121 A NZ 598121A
- Authority
- NZ
- New Zealand
- Prior art keywords
- nitroimidazooxazines
- oxazine
- imidazo
- trifluoromethoxy
- dihydro
- Prior art date
Links
- YVMGQODAKAHLHB-UHFFFAOYSA-N 3-nitroimidazo[4,5-e]oxazine Chemical class O1N=C([N+](=O)[O-])C=C2N=CN=C21 YVMGQODAKAHLHB-UHFFFAOYSA-N 0.000 title 1
- 230000002365 anti-tubercular Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- PBMCMZFEDXCLOG-SFHVURJKSA-N (6s)-2-nitro-6-[[4-[[4-(trifluoromethoxy)phenyl]methyl]phenyl]methoxy]-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine Chemical compound O([C@H]1CN2C=C(N=C2OC1)[N+](=O)[O-])CC(C=C1)=CC=C1CC1=CC=C(OC(F)(F)F)C=C1 PBMCMZFEDXCLOG-SFHVURJKSA-N 0.000 abstract 1
- JRMJATJTHVCYRK-SFHVURJKSA-N (6s)-2-nitro-6-[[6-[2-[4-(trifluoromethoxy)phenyl]ethynyl]pyridin-3-yl]methoxy]-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine Chemical compound O([C@H]1CN2C=C(N=C2OC1)[N+](=O)[O-])CC(C=N1)=CC=C1C#CC1=CC=C(OC(F)(F)F)C=C1 JRMJATJTHVCYRK-SFHVURJKSA-N 0.000 abstract 1
- AFVACAZNAUREGB-HNNXBMFYSA-N (6s)-6-[[4-[2-chloro-4-(trifluoromethoxy)phenyl]phenyl]methoxy]-2-nitro-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine Chemical compound O([C@H]1CN2C=C(N=C2OC1)[N+](=O)[O-])CC(C=C1)=CC=C1C1=CC=C(OC(F)(F)F)C=C1Cl AFVACAZNAUREGB-HNNXBMFYSA-N 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23039609P | 2009-07-31 | 2009-07-31 | |
| PCT/US2010/043906 WO2011014774A1 (en) | 2009-07-31 | 2010-07-30 | Nitroimidazooxazines and their uses in anti-tubercular therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ598121A true NZ598121A (en) | 2013-04-26 |
Family
ID=42937154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ598121A NZ598121A (en) | 2009-07-31 | 2010-07-30 | Nitroimidazooxazines and their uses in anti-tubercular therapy |
Country Status (12)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9051333B2 (en) | 2011-04-15 | 2015-06-09 | Otsuka Pharmaceutical Co., Ltd. | 6,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericides |
| CN104059082B (zh) * | 2013-03-21 | 2016-08-03 | 苏州迈泰生物技术有限公司 | 硝基咪唑杂环类化合物及其在制备治疗结核病药物中的应用 |
| KR101682356B1 (ko) | 2014-11-04 | 2016-12-06 | 한국화학연구원 | 이미다조 옥사진 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학이성질체 및 이를 유효성분으로 함유하는 약제학적 조성물 |
| US10227362B2 (en) | 2015-01-29 | 2019-03-12 | Medshine Discovery Inc. | Anti-pulmonary tuberculosis nitroimidazole derivative |
| CN108047248A (zh) * | 2018-02-12 | 2018-05-18 | 丹诺医药(苏州）有限公司 | 噁唑烷酮-硝基咪唑类偶联分子的应用 |
| CN113527331B (zh) * | 2020-04-17 | 2024-05-28 | 南京长澳医药科技有限公司 | 硝基咪唑类衍生物及其制备方法和用途 |
| CN113355439A (zh) * | 2021-06-07 | 2021-09-07 | 深圳市普瑞康生物技术有限公司 | 一种结核分枝杆菌潜伏感染及发病的新型组合检测方法 |
| CN114469946B (zh) * | 2022-02-24 | 2023-10-24 | 首都医科大学附属北京胸科医院 | 德拉马尼作为cxcl10抑制剂的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ284592B6 (cs) | 1994-03-08 | 1999-01-13 | American Home Products Corporation | Thiazolidindionové deriváty a farmaceutický prostředek s jejich obsahem |
| US5668127A (en) | 1995-06-26 | 1997-09-16 | Pathogenesis Corporation | Nitroimidazole antibacterial compounds and methods of use thereof |
| US6087358A (en) * | 1995-06-26 | 2000-07-11 | Pathogenesis Corporation | Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof |
| AR041198A1 (es) * | 2002-10-11 | 2005-05-04 | Otsuka Pharma Co Ltd | Compuesto 2,3-dihidro-6-nitroimidazo[2,1-b] oxaxol, y composiciones farmaceuticas que lo contienen |
| CN100497345C (zh) * | 2003-10-31 | 2009-06-10 | 大塚制药株式会社 | 治疗结核病的2,3-二氢-6-硝基咪唑并[2,1-b]唑化合物 |
| ATE382609T1 (de) | 2004-01-16 | 2008-01-15 | Sumitomo Chemical Co | Malononitrilverbindungen als pestizide |
| TWI300409B (en) * | 2004-02-18 | 2008-09-01 | Otsuka Pharma Co Ltd | Method for producing 4-nitroimidazole compound |
| WO2006043121A1 (en) * | 2004-10-20 | 2006-04-27 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| KR20080038369A (ko) * | 2005-07-28 | 2008-05-06 | 버텍스 파마슈티칼스 인코포레이티드 | 카스파제 억제제 프로드럭 |
| KR20080079280A (ko) * | 2005-12-23 | 2008-08-29 | 노파르티스 아게 | 니트로이미다졸 화합물 |
| CA2712613C (en) * | 2008-03-26 | 2017-02-28 | Global Alliance For Tb Drug Development | Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones |
-
2010
- 2010-07-30 IN IN1414DEN2012 patent/IN2012DN01414A/en unknown
- 2010-07-30 KR KR1020127005320A patent/KR101746482B1/ko not_active Expired - Fee Related
- 2010-07-30 RU RU2012107176/04A patent/RU2542988C2/ru not_active IP Right Cessation
- 2010-07-30 WO PCT/US2010/043906 patent/WO2011014774A1/en active Application Filing
- 2010-07-30 CN CN201080041453.9A patent/CN102753558B/zh not_active Expired - Fee Related
- 2010-07-30 ES ES10742955.7T patent/ES2536997T3/es active Active
- 2010-07-30 CA CA2769359A patent/CA2769359C/en not_active Expired - Fee Related
- 2010-07-30 EP EP10742955.7A patent/EP2459571B1/en not_active Not-in-force
- 2010-07-30 JP JP2012523087A patent/JP5781072B2/ja not_active Expired - Fee Related
- 2010-07-30 AU AU2010278777A patent/AU2010278777B2/en not_active Ceased
- 2010-07-30 NZ NZ598121A patent/NZ598121A/xx not_active IP Right Cessation
- 2010-07-30 BR BR112012002278-4A patent/BR112012002278A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102753558B (zh) | 2014-10-15 |
| AU2010278777B2 (en) | 2015-05-07 |
| JP5781072B2 (ja) | 2015-09-16 |
| ES2536997T3 (es) | 2015-06-01 |
| AU2010278777A1 (en) | 2012-03-01 |
| KR20120084713A (ko) | 2012-07-30 |
| EP2459571B1 (en) | 2015-03-11 |
| JP2013500996A (ja) | 2013-01-10 |
| CA2769359C (en) | 2017-03-07 |
| WO2011014774A1 (en) | 2011-02-03 |
| KR101746482B1 (ko) | 2017-06-27 |
| RU2012107176A (ru) | 2013-09-10 |
| CA2769359A1 (en) | 2011-02-03 |
| IN2012DN01414A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-06-05 |
| CN102753558A (zh) | 2012-10-24 |
| RU2542988C2 (ru) | 2015-02-27 |
| EP2459571A1 (en) | 2012-06-06 |
| BR112012002278A2 (pt) | 2020-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ598121A (en) | Nitroimidazooxazines and their uses in anti-tubercular therapy | |
| MX2009012390A (es) | Uso de compuestos de 4-(pirrolidin-1-il)quinolina para exterminar microorganismos clinicamente latentes. | |
| NO20085217L (no) | Effektive pyrimidinderivater i behandlingen av kreft | |
| PH12012501630A1 (en) | Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd | |
| NZ544244A (en) | Dual NK1/NK3 antagonists for treating schizophrenia | |
| PH12012501631A1 (en) | Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd | |
| EP2604610A4 (en) | PHTHALAZINONE KETONE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL USE | |
| GB0502258D0 (en) | Compounds and their use | |
| NZ603895A (en) | Novel phosphodiesterase inhibitors | |
| PH12012502438A1 (en) | Morpholino pyrimidines and their use in therapy | |
| IN2012DN01453A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| UA92637C2 (en) | Pyridine[3,4-b]pyrazinones | |
| NZ600430A (en) | Spiro-oxindole mdm2 antagonists | |
| MX2010008921A (es) | Derivados de oxazolidinona. | |
| CO5570678A2 (es) | N-alquilo-4-metileneamino-3-hidroxilo-2-piridonas como anti- microbianos | |
| IL189194A (en) | Benzimidazoles are conserved as kinase inhibitors and their use in the preparation of cancer drugs | |
| EA201070544A1 (ru) | Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений | |
| MX2009010642A (es) | Antibioticos de oxazolidinona. | |
| NZ593004A (en) | Azaazulene compounds | |
| SI2219647T1 (sl) | Terapevtska uporaba spojin, ki imajo kombinacijo sert, 5-ht2 in 5-ht1a aktivnosti | |
| WO2009030224A3 (de) | Neue chinazolin- verbindungen und ihre verwendung zur therapie von krebserkrankungen | |
| BRPI0908635B8 (pt) | composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica | |
| EP4252855A3 (en) | Compounds for use in the treatment of brain metastases in a patient with erbb2+ breast cancer | |
| MX2013002384A (es) | Compuestos quinazolina y metodos para utilizarlos. | |
| GEP20146063B (en) | Solid pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 JUL 2017 BY CPA GLOBAL Effective date: 20140626 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 JUL 2018 BY CPA GLOBAL Effective date: 20170622 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 JUL 2019 BY CPA GLOBAL Effective date: 20180705 |
|
| LAPS | Patent lapsed |